Joe
05-16-2006, 06:03 PM
I talked to Nexcura at length today and this is a valid survey. We will also be featuring some links to other Nexcura resources in a few weeks.
Regards
Joe
At some point in the past you used an online resource called NexProfiler™ Treatment Option Tool for Breast Cancer. At the time you registered for this treatment decision tool, you indicated that you would be interested in being contacted by NexCura, which operates the NexProfiler Tool for Cancer, for opportunities to participate in market research.
We thought you would like to know that there is a research group recruiting patients or caregivers for an online "bulletin board" extended forum about breast cancer treatment. The extended forums will take place over six weeks from June 27th through August 7th. We would be asking participants to share information on the progression of their condition, their feelings related to their condition, and how they are currently treating their condition.
We recognize that dealing with breast cancer can be challenging and that you may not be interested in participating in this research. If that is the case, please delete this email.
A bulletin board is an online forum where respondents can log in to chat and answer questions posted by a moderator. Questions will be posted each week for 6 weeks and a moderator will be reviewing your responses and asking any additional questions that may come up. We ask that participants access the board at their own convenience each week, for about 45 minutes per week. The boards can be accessed anytime day or night to post thoughts, or add any additional comments, etc. Also, not all questions need to be answered at the same time. You can always return to the bulletin boards later in the week to finish responding to the questions posted.
To thank you for your participation we will send you cash honorariums every three weeks: $70 after the first three weeks and $110 after the second three weeks for a total of $180 over the full six weeks, if you qualify and complete the research.
In order to participate in this panel, you must be a patient (or the caregiver of a patient) who has been diagnosed with metastatic (stage IV) breast cancer and is hormone receptor positive.
If you are available to participate June 27 - August 7, and are interested in participating, please send an email directly to HQRRec@harrisinteractive.net (HQRRec@harrisinteractive.net?subject=NexCura_J269 68), including "NexCura" and the code "J26968" in the subject line with the following information:
Your first and last name
Your preferred telephone number (including area code and time zone) to be contacted to see if you qualify
The most convenient time of day to contact you
A Harris Interactive representative will contact you by telephone within the next few days to ask you a few additional questions to ensure that you meet our study qualifications.
Thank you for your interest in this research!
Questions about this research?
You may contact us at:
Email: research@education.nexcura.com (research@education.nexcura.com)
Phone: 1-877-422-3228
Patient Information Services
NexCura, A Thomson Business
1725 Westlake Ave. N., Suite 300
Seattle, WA 98109
If you wish to review NexCura's Privacy Statement, visit:
http://www.nexcura.com/nexcura/Nexcura_Privacy.asp (http://www.nexcura.com/nexcura/Nexcura_Privacy.asp)
This message and offer for this program has been brought to you by Harris Interactive and when you send an email to the address listed above, you will be providing information to Harris Interactive. Harris Interactive posts an online privacy policy at http://www.harrisinteractive.com/about/privacy.asp (http://www.harrisinteractive.com/about/privacy.asp) which we suggest you read.
For comments or questions contact Rose Walker or John Milton at the Harris Interactive Survey Help Desk: http://surveyhelp.harrispollonline.com/index.asp?ID=&surveycode; (http://surveyhelp.harrispollonline.com/index.asp?ID=&surveycode;)
Or write to: Harris Interactive, attn: Rose Walker, 135 Corporate Woods, Rochester, NY 14623-1457.
Regards
Joe
At some point in the past you used an online resource called NexProfiler™ Treatment Option Tool for Breast Cancer. At the time you registered for this treatment decision tool, you indicated that you would be interested in being contacted by NexCura, which operates the NexProfiler Tool for Cancer, for opportunities to participate in market research.
We thought you would like to know that there is a research group recruiting patients or caregivers for an online "bulletin board" extended forum about breast cancer treatment. The extended forums will take place over six weeks from June 27th through August 7th. We would be asking participants to share information on the progression of their condition, their feelings related to their condition, and how they are currently treating their condition.
We recognize that dealing with breast cancer can be challenging and that you may not be interested in participating in this research. If that is the case, please delete this email.
A bulletin board is an online forum where respondents can log in to chat and answer questions posted by a moderator. Questions will be posted each week for 6 weeks and a moderator will be reviewing your responses and asking any additional questions that may come up. We ask that participants access the board at their own convenience each week, for about 45 minutes per week. The boards can be accessed anytime day or night to post thoughts, or add any additional comments, etc. Also, not all questions need to be answered at the same time. You can always return to the bulletin boards later in the week to finish responding to the questions posted.
To thank you for your participation we will send you cash honorariums every three weeks: $70 after the first three weeks and $110 after the second three weeks for a total of $180 over the full six weeks, if you qualify and complete the research.
In order to participate in this panel, you must be a patient (or the caregiver of a patient) who has been diagnosed with metastatic (stage IV) breast cancer and is hormone receptor positive.
If you are available to participate June 27 - August 7, and are interested in participating, please send an email directly to HQRRec@harrisinteractive.net (HQRRec@harrisinteractive.net?subject=NexCura_J269 68), including "NexCura" and the code "J26968" in the subject line with the following information:
Your first and last name
Your preferred telephone number (including area code and time zone) to be contacted to see if you qualify
The most convenient time of day to contact you
A Harris Interactive representative will contact you by telephone within the next few days to ask you a few additional questions to ensure that you meet our study qualifications.
Thank you for your interest in this research!
Questions about this research?
You may contact us at:
Email: research@education.nexcura.com (research@education.nexcura.com)
Phone: 1-877-422-3228
Patient Information Services
NexCura, A Thomson Business
1725 Westlake Ave. N., Suite 300
Seattle, WA 98109
If you wish to review NexCura's Privacy Statement, visit:
http://www.nexcura.com/nexcura/Nexcura_Privacy.asp (http://www.nexcura.com/nexcura/Nexcura_Privacy.asp)
This message and offer for this program has been brought to you by Harris Interactive and when you send an email to the address listed above, you will be providing information to Harris Interactive. Harris Interactive posts an online privacy policy at http://www.harrisinteractive.com/about/privacy.asp (http://www.harrisinteractive.com/about/privacy.asp) which we suggest you read.
For comments or questions contact Rose Walker or John Milton at the Harris Interactive Survey Help Desk: http://surveyhelp.harrispollonline.com/index.asp?ID=&surveycode; (http://surveyhelp.harrispollonline.com/index.asp?ID=&surveycode;)
Or write to: Harris Interactive, attn: Rose Walker, 135 Corporate Woods, Rochester, NY 14623-1457.